Ziemer Ophthalmic Systems AG
9
0
0
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
40%
2 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Comparison of Femto-laser and Manually Created Clear Corneal Incisions During Cataract Surgery
Role: lead
CLEAR Procedure in Myopia and Astigmatism - Registry Study
Role: lead
FLACS in Pediatric Patients Using FEMTO LDV-Z8
Role: lead
Efficacy and Safety of CLEAR in Myopia and Astigmatism in Chinese Population
Role: lead
Safety and Efficacy of FLACS With the FEMTO LDV Z8 Laser Compared to Conventional Cataract Surgery in Chinese Patients
Role: lead
LASIK Surgery With a New Laser for the Treatment of Myopia Without Astigmatism
Role: lead
Cataract Surgery: Femto LDV Z8 Versus Conventional
Role: lead
Galilei Lens Professional vs. Predicate Devices: a Comparison Study
Role: lead
A Comparison of Two Devices for Taking Measurements of the Eye to Assist in Lens Selection for Cataract Surgery
Role: lead
All 9 trials loaded